FOUR-YEAR RESULTS OF A PHASE 2 STUDY OF THE CATESPIN K INHIBITOR ODANACATIB IN POSTMENOPAUSAL WOMEN WITH LOW BONE MINERAL DENSITY: EFFECTS ON BONE TURNOVER MARKERS

OSTEOPOROSIS INTERNATIONAL(2011)

引用 0|浏览1
暂无评分
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要